Multiple Myeloma News

Rumsfeld, 88, led the Pentagon for presidents Gerald Ford and George W. Bush, and was one of most influential government leaders of the first decade of the 21st century. He died at his home in Taos, N.M.

Convalescent plasma, obtained from people who have had COVID-19 and have recovered, provides such patients with antibodies.

A personalized cancer vaccine proved possible to manufacture and was well tolerated in an early phase I clinical trial, researchers said.

Ide-cel is the first CAR T-cell therapy to gain approval for use in multiple myeloma. It is also the first CAR T-cell therapy to target B-cell maturation antigen.

An experimental drug for multiple myeloma may work on the coronavirus, a new study shows.

For patients with heavily-pretreated multiple myeloma, the strong responses seen with the new CAR T-cell treatment have also been prolonged.

Researchers attempt to turn immune cells into unerring killers of multiple myeloma cells

43 percent of study patients with the blood cancer had a complete response, researchers report

Response rate doubled for patients with this blood cancer, study finds

Multiple myeloma patients saw survival gains when elotuzumab was added to treatment

Veteran TV journalist has multiple myeloma, which attacks white blood cells in bone marrow

Adding the intravenous bone drug Zometa to chemotherapy improves survival in patients with the blood cancer multiple myeloma, new research from the U.K. shows.

The FDA has approved thalidomide -- a drug known to cause severe birth defects -- to help treat newly diagnosed multiple myeloma, a cancer of the bone marrow.

WebMD Asks the Experts About Multiple Myeloma and Thalidomide

Scientists Use Tumor to Fight Tumor in Multiple Myeloma

Thalidomide, a drug notorious for producing birth defects in babies born to women who took it for morning sickness in the 1960s, is proving to be effective for people with advanced multiple myeloma, a cancer of the bone marrow.

Thalidomide, a drug best known for causing horrific birth defects, is prolonging the lives of people with a rare form of cancer, according to a study in The New England Journal of Medicine Thursday.